Adverum Biotechnologies
ADVM
ADVM
68 hedge funds and large institutions have $118M invested in Adverum Biotechnologies in 2024 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 13 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5.35% more ownership
Funds ownership: 80.72% → 86.07% (+5.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
50% less capital invested
Capital invested by funds: $237M → $118M (-$119M)
Holders
68
Holding in Top 10
2
Calls
$414K
Puts
$30K
Top Buyers
| 1 | +$7.77M | |
| 2 | +$7.5M | |
| 3 | +$7.44M | |
| 4 |
Goldman Sachs
New York
|
+$2.72M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.8M |
Top Sellers
| 1 | -$9.29M | |
| 2 | -$7.43M | |
| 3 | -$6.21M | |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$4.12M |
| 5 |
Morgan Stanley
New York
|
-$2.97M |